martes, 14 de marzo de 2017

Public Meeting on Patient-Focused Drug Development for Sarcopenia

For Women

u s food and drug administration

womens health alert - fda office of womens health

Public Meeting on Patient-Focused Drug Development for Sarcopenia

a1



On April 6, 2017, from 1:00 pm to 5:00 pm, FDA is conducting a public meeting on Patient-Focused Drug Development (PFDD) for Sarcopenia. FDA is interested in obtaining patient perspectives on the impact of sarcopenia on daily life and patient views on treatment approaches. Registration to attend the meeting must be received by April 6, 2017.
In addition to providing input at the public meeting, stakeholders are invited to provide their perspectives on the discussion questions through the public docket. The docket closes on June 6, 2017.

No hay comentarios:

Publicar un comentario en la entrada